Le Lézard
Classified in: Health
Subjects: CCA, FVT

Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement


INDIANAPOLIS, April 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2024 financial results on April 30, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.

The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.

About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news or follow us on Facebook, Instagram and LinkedIn. F-LLY

Refer to:     

Jordan Bishop; [email protected]; 317-473-5712 (Media)


Joe Fletcher; [email protected]; 317-296-2884 (Investors)

 

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

 

SOURCE Eli Lilly and Company


These press releases may also interest you

at 10:20
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents for the...

at 10:18
AISAP, whose AI-powered Point Of Care Assisted Diagnosis (POCAD)tm solution is transforming the medical ultrasound industry, announced its seed funding round today. The company secured $13 million, led by Harel Insurance Investments & Financial...

at 10:17
Virginia Cancer Specialists, the largest private cancer practice in...

at 10:08
A center with heart celebrated its fifth anniversary by inviting the entire High Desert community to join the fun. Inland Empire...

at 10:07
SonoVascular, Inc., a private medical device company focused on the development of its SonoThrombectomytm System, a novel pharmaco-mechanical ultrasound facilitated thrombectomy system that utilizes microbubble-mediated cavitation as a core enabling...

at 10:03
The report titled "Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Indication, End-use - Global Forecast 2024-2030" is now available...



News published on and distributed by: